Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular

D S Blondheim1, L E Jacobs, M N Kotler

  • 1Department of Medicine, Albert Einstein Medical Center, Philadelphia, PA.

American Heart Journal
|September 1, 1991
PubMed

Insights

Mitral regurgitation (MR) in dilated cardiomyopathy patients is linked to fewer left ventricular thrombi but significantly reduced survival rates. This finding highlights MR as a key indicator of poor prognosis.

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiovascular Research

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • Left ventricular thrombi (LVT) are a known complication of DCM, increasing embolic risk.
  • Mitral regurgitation (MR) is common in DCM, but its prognostic implications require further elucidation.

Purpose of the Study:

  • To investigate the relationship between mitral regurgitation (MR) and left ventricular thrombi (LVT) in patients with dilated cardiomyopathy (DCM).
  • To assess the impact of MR on apical flow velocities and survival in DCM patients.
  • To determine if MR can serve as a noninvasive marker for prognosis in DCM.

Main Methods:

  • Echocardiography (2D, pulsed, and color Doppler) was used in 91 DCM patients.
  • Assessment included quantification of MR, measurement of apical flow velocities, and detection of LVT.
  • Follow-up data was collected to evaluate patient survival.

Main Results:

  • MR was detected in 57% of patients; LVT in 40%.
  • The co-occurrence of MR and LVT was infrequent (8%).
  • Patients with MR exhibited significantly higher apical flow velocities and markedly decreased survival rates (22% vs. 60% at 32 months).

Conclusions:

  • Mitral regurgitation in DCM is associated with reduced left ventricular thrombus formation.
  • MR is a sensitive, noninvasive marker indicating significantly decreased survival in dilated cardiomyopathy.
  • Even mild MR portends a worse prognosis in DCM patients.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...